[Proglumetacin: a simple and practical anti-inflammatory agent for the treatment of hospitalized orthopedic patients].
Forty-six in-patients with osteoarticular and tendon inflammatory, traumatic, degenerative and neoplastic diseases were treated with 600 mg/day of proglumetacin for variable periods ranging between 16 and 60 days. Therapeutic efficacy was considerable, with a significant improvement of all symptoms, regardless of the disease condition the patients were suffering from. Tolerance resulted more than satisfactory, as in no case it was rated less than "good".